Evertogen Life Sciences

We develop, manufacture and market finished dosages for companies around the world. With well-planned and equipped processes & systems in place, we cater to the requirements of our clients in a timely and cost-effective manner, bringing greater predictability to their business. Pharmaceutical companies – pillars of the healthcare system – face multiple challenges of adhering to the regulations, providing affordable generics to patients and maintaining a diverse portfolio with the constant pressure for introduction of new products. At Evertogen, we are cognizant of these complexities and partner with clients in the face of stiff challenges to help them achieve their objectives. Evertogen’s journey began with a single client in July 2013; today we are proud partners of about forty clients spread across the globe (Europe, Canada, South Africa, Australia, Ukraine,South East Asia,LATAM & others). Our growth stems from our dynamism and the promise of quality, accuracy, transparency & speed, with which we relentlessly deliver to all our clients. With a flat organization structure in place,the employees have the freedom to communicate and function in a fair & collaborative environment. Our consistent focus on meeting global regulatory standards has enabled us to successfully attain GMP certification from TGA, Australia, Ukrainian MOH, EUGMP , Health Canada, UAE and WHO GMP . Our presence in the Special Economic Zone (SEZ) enables us to offer competitive prices to our customers. With a clear vision of rendering unmatched services to our customers and without any conflict of interests in the global market, we have earned ourselves a reputation for quality and transparency in a short period of time. Looking ahead, apart from oral solid dosage formulation, we will be exploring to venturing into liquid dosage formulation, and building our capabilities around the OTC segment.